Literature DB >> 3263256

Nonnarcotic drug use over an addiction career--a study of heroin addicts in Baltimore and New York City.

D N Nurco1, T W Kinlock, T E Hanlon, J C Ball.   

Abstract

Detailed interview data from 250 male narcotic addicts attending methadone maintenance treatment centers in Baltimore and New York City were used to confirm and extend previous findings regarding the frequency of nonnarcotic drug abuse among relevant addict subgroups. Consistent with earlier results, abuse of nonnarcotic drugs in general, and particularly cocaine, was higher during periods of addiction than during periods of nonaddiction. Overall, marijuana and cocaine were the two main drugs of abuse, but variations were present according to addiction status period, city, and ethnic group membership. Relationships between cocaine use and specific types of criminal activity were also examined. It was found that there were high associations between cocaine use and several different kinds of crime.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263256     DOI: 10.1016/0010-440x(88)90060-0

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  3 in total

1.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 2.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

3.  Impact of cannabis use during stabilization on methadone maintenance treatment.

Authors:  Jillian L Scavone; Robert C Sterling; Stephen P Weinstein; Elisabeth J Van Bockstaele
Journal:  Am J Addict       Date:  2013 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.